Tuesday 31 January 2017

United States Contrast Media Injectors Market Analysis, Size, Share, Trends, Estimates And Forecasts to 2022




"The Report United States Contrast Media Injectors Market Outlook to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

GlobalDatas new report, "United States Contrast Media Injectors Market Outlook to 2022", provides key market data on the United States Contrast Media Injectors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Angiographic Injectors, Computed Tomography (CT) Injectors and Magnetic Resonance Imaging (MRI) Injectors.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Contrast Media Injectors market segements - Angiographic Injectors, Computed Tomography (CT) Injectors and Magnetic Resonance Imaging (MRI) Injectors.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the United States Contrast Media Injectors market.
- Key players covered include Bayer HealthCare AG, Bracco Imaging S.p.A. and Others.

Get Sample Copy Of This Report @

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Contrast Media Injectors Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Contrast Media Injectors Market, United States 6
3.1 Contrast Media Injectors Market, United States, Revenue ($m), 2008-2015 6
3.2 Contrast Media Injectors Market, United States, Revenue ($m), 2015-2022 8
3.3 Contrast Media Injectors Market, United States, Volume (Units), 2008-2015 10
3.4 Contrast Media Injectors Market, United States, Volume (Units), 2015-2022 12
3.5 Contrast Media Injectors Market, United States, Average Price ($), 2008-2022 14
3.6 Contrast Media Injectors Market, United States, Distribution Share by Revenue ($m), 2014-2015 15
3.7 Contrast Media Injectors Market, United States, Company Share by Revenue ($m), 2015 16
4 Overview of Key Companies in United States, Contrast Media Injectors Market 17
4.1 Bayer HealthCare AG 17
4.1.1 Company Overview 17
4.2 Guerbet SA 17
4.2.1 Company Overview 17
4.3 Bracco Imaging SpA 17
4.3.1 Company Overview 17
5 Contrast Media Injectors Market Pipeline Products 18
6 Recent Developments 19
6.1 Corporate Communications 19
6.1.1 Jul 26, 2016: Merit Medical Announces Appointment of New Director 19
6.2 Financial Announcements 19
6.2.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 19
6.2.2 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 20
6.2.3 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 21
6.2.4 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 21
6.3 Strategy And Business Planning 22

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Menswear Market Analysis, Size, Share, Growth, Trends and Forecast 2016-2021



"The Report The UK Menswear Market 2016-21 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Summary

The menswear market will be the strongest performer out of all clothing sectors with estimated growth of 19.9% in the next five years. A big contributor behind this growth is that men are becoming more conscious of trends and their appearance, presenting opportunities for players to gain sales and share through more frequent newness and more trend-led, fast-fashion products. However, the sector is not without its problems, as the weakened pound will force price rises and put added pressure on retailer margins.

Key Findings

- The athleisure trend continues to boost menswear sales. Mens growing interest in health and fitness is driving the trend for athleisure clothing, which will fuel the demand for high quality sports products, and sportswear that can be easily worn as casualwear. This provides an opportunity for sports retailers JD Sports, Nike and Sports Direct, as well as non-specialists such as Whistles and departments stores to expand their premium sports offers.

- Menswear is an increasingly competitive market with more retailers entering the market and expanding their ranges. Value players, which previously overlooked menswear in favour for womenswear are particularly keen to invest due to the increased interest by men in trend-led products. New Look rolled out standalone menswear stores in 2016, while Boohoo.com launched a dedicated menswear platform.

- With both premium and value price points outperforming, the midmarket has been squeezed with growth of just 8% between 2011 and 2016. Mens growing interest in value clothing, triggered by a desire for more affordable fashion, means sales of value price point clothing will be the fastest growing in the five years to 2021. However, mens focus on quality and longevity will mean that brands and premium price points will also outperform the wider market.

Get Sample Copy Of This Report @

Synopsis

The UK Menswear Market 2016-21 is part of GlobalDatas sector analysis series, which provides deep quantitative and qualitative insight into the menswear market, with forecasts up to 2021. Key trends in the market are analyzed, including the impact of inflation, the growing importance of fashion, intensifying competition and how to reach underserved shoppers. The report provides in-depth analysis of the following: key issues, strategies for success, market size and forecasts, retailer profiles and their market shares, and future outlook. Our comprehensive consumer chapter also provides a detailed insight into what, how and where consumers are buying menswear.

ReasonsToBuy

- Use GlobalDatas market size price segmentation forecast to 2021 to uncover which menswear retailers will be the most squeezed, and uncover how retailers can hold onto shoppers and encourage spend.
- Use our retailer positioning map to identify gaps in the market and discover those consumers who are currently underserved. It can also be used to understand how, as a retailer, you can differentiate yourself in an increasingly crowded market.
- Use our average spend per head data by age group to identify which consumers to target and how to drive further spend from them.
- Learn from the best and worst retailers for instore visual merchandising, online propositions and trend incorporation by using our company analysis and retailer profiles, and apply this knowledge to your own business.
- Use our consumer data on what clothing sizes men bought across different product categories to help with more precise and accurate investment when sourcing and buying menswear.

Table of Contents

The hot issues
What people buy
Where people shop
How people shop
Why people shop
About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Learn details of the Smoking Tobacco in Belgium and Luxembourg



"The Report Smoking Tobacco in Belgium and Luxembourg provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

The combined Belgium and Luxembourg smoking tobacco market amounted to 13,650 Tons in 2015, which equates to an annual per capita consumption rate of 1,214g, high by international comparisons, although inflated by cross border purchasing activity. Fine cut tobacco accounts for 99.7% of sales across UEBL, with pipe tobacco just a minor niche


Key Findings

- Between 1990-2015, the smoking tobacco market in Belgium increased by 180.8% with Cigar and cigarillo volumes fell by 40.6% in 2015, as smoking tobacco strengthened its position in the market.

- The smoking tobacco market is led by JTI accounting for 23.1% of total market in Belgium and Luxembourg. This is followed by Imperial Tobacco, PMI, and BAT. Per capita consumption is forecast at 1,035g in 2025, 14.5% down on 2015.

Get Sample Copy Of This Report @

Synopsis

Smoking Tobacco in Belgium and Luxembourg is an analytical report by GlobalData that provides extensive and highly detailed current and future market trends in the Australian tobacco market. It covers market size and structure along with per capita and overall consumption. Additionally, it focuses on brand data, retail pricing, prospects, and forecasts for sales and consumption until 2025.

ReasonsToBuy

- Get a detailed understanding of consumption to align your sales and marketing efforts with the latest trends in the market.
- Identify the areas of growth and opportunities, which will aid effective marketing planning.
- The differing growth rates in regional product sales drive fundamental shifts in the market.
- This report provides detailed, authoritative data on these changes - prime intelligence for marketers.
- Understand the market dynamics and essential data to benchmark your position and to identify where to compete in the future.
Table of Contents
Introduction
Market context
Market size and structure
Production and trade
Taxation and retail prices
Manufacturers and brands
The smoking population
Operating constraints
Distribution
Prospects and forecasts
Appendix


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Global Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Clinical Trials Review, H2, 2016




"The Report Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

GlobalData's clinical trial report, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2016" provides an overview of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.


Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Get Sample Copy Of This Report @

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Methicillin-Resistant Staphylococcus aureus (MRSA) Infections 32
Dec 08, 2016: Citius Moves Forward with Mino-Lok Phase 3 Trial 32
Nov 29, 2016: MicuRx Initiates Phase 1 Clinical Trial in U.S. for Novel Antibiotic Agent MRX-4 32
Nov 08, 2016: HKU Chemists achieve breakthrough in antibacterial drug research 33
Oct 26, 2016: Tetraphase Pharmaceuticals Announces Eight Data Presentations at IDWeek 2016 33

Related Latest Report under Pharmaceutical category:




About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Report delivers insight into the Global Malignant Mesothelioma Clinical Trials Review, H2, 2016




"The Report Malignant Mesothelioma Global Clinical Trials Review, H2, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Summary

GlobalData's clinical trial report, Malignant Mesothelioma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Mesothelioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Mesothelioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.


Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Get Sample Copy Of This Report @

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Malignant Mesothelioma Therapeutics Clinical Trials 27
Prominent Drugs 28
About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Monday 30 January 2017

Global Writing and Marking Instruments Market Forcast To Grow At CAGR Of 4.76% Between 2017-2021



"The Report Global Writing and Marking Instruments Market 2017-2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

About Writing and Marking Instruments

Among stationery products, writing instruments, used by all age groups, primarily have universal application in academic, corporate, and personal requirements. However, despite increased use of gadgets and digitalization for the same purpose on a different medium instead of paper-based material, the market is expected to grow. This is owing to initiatives, such as innovation and expansion of distribution channels, being undertaken by vendors to provide differentiate products to end-users. In addition, this will help vendors gain a competitive advantage.

Technavios analysts forecast the global writing and marking instruments market to grow at a CAGR of 4.76% during the period 2017-2021.


Covered in this report

The report covers the present scenario and the growth prospects of the global writing and marking instruments market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales of various writing and marking instruments to commercial and non-commercial consumers.

The market is divided into the following segments based on geography:
APAC
Europe
North America
ROW

Technavio's report, Global Writing and Marking Instruments Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Crayola
Faber-Castell
Mitsubishi Pencil
Newell Brands
PILOT
BIC
Get Sample Copy Of This Report @

Other prominent vendors
A.T. Cross
Caran d'Ache
Hindustan Pencils
Hoshan Pan Gulf
KOH-I-NOOR HARDTMUTH
Kokuyo Camlin
Linc Pen & Plastics
Montblanc
Pelikan
Pentel of America
Shanghai M&G Stationery
Staedtler
Stabilo International
Zebra Pen

Market driver
Emergence of luxury segment
For a full, detailed list, view our report

Market challenge
Threat from counterfeit products and local brands
For a full, detailed list, view our report

Market trend
Increase in number of home offices
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
Other prominent vendors
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Global stationery market
PART 06: Stationery supplies - distribution network
PART 07: Market overview
Global writing and marking instruments market
Five forces analysis
PART 08: Market segmentation by product
Global writing and marking instruments market by product
Pens
Pencils
Coloring writing instruments
Markers and highlighters
Writing accessories
Geographical segmentation
Global writing and marking instruments market by geography
Writing and marking instruments market in APAC
Writing and marking instruments market in Europe
Writing and marking instruments market in North America
Writing and marking instruments market in ROW
PART 09: Key leading countries
PART 10: Market drivers
Emergence of luxury segment
Rising product innovation and R&D
Personalization and customization of pens
Growth of multi-function pens
About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074